Value of the sequential treatment with defibrinating agents and plasminogenic urokinase in thromboembolic disease
Charbonnier, B.; Griguer, P.; Brochier, M.; Monpère, C.; Raynaud, P.
Agressologie Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 24(11): 587-590
1983
ISSN/ISBN: 0002-1148 PMID: 6670690 Document Number: 220079
Document emailed within 1 workday
Related Documents
Ogawa, S.; Naruse, T. 1981: Effects of various anti-platelet drugs and defibrinating agents on experimental glomerulonephritis in rats Nihon Jinzo Gakkai Shi 23(3): 309-322Rey, M-Antoinette.; Bron, Cédric.; Haesler, E.; Mazzolai, L. 2009: Treatment and prevention of venous thromboembolic disease: what's new? Revue Medicale Suisse 5(189): 316-320
Westrich, G.H.; Sánchez, P.M. 2002: Prevention and treatment of thromboembolic disease: an overview Instructional Course Lectures 51: 471-480
Vujadinović, B.; Baljozović, A.; Anojcić, S. 1970: Personal experiences in the treatment of thromboembolic disease with streptase Srpski Arhiv Za Celokupno Lekarstvo 98(3): 435-439
Carlsen, E.; Evensen, S.A. 1983: Thromboembolic disease in patients with ulcerative colitis. Treatment and prevention Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(25): 1759-1761
Mismetti, P.; Laporte-Simitsidis, S.; Leizorovicz, A.; Decousus, H. 1997: Heparins and curative treatment of venous thromboembolic disease: meta-analysis Therapie 52(1): 47-52
Thery, C.; Prat, A.; Asseman, P.; Bauchart, J.J.; Michon, P.; Lesenne, M.; Jude, B. 1997: Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease Therapie 52(3): 165-168
Nabatoff, R.A.; Blum, L.; Touroff, A.S. 1970: Long-term sequelae of common femoral vein ligation in the treatment of thromboembolic disease Surgery 67(2): 272-276
Marco R. de Groot; Njo, T.L.; Marinus van Marwijk Kooy and Harry R. Bueller 2000: Abrupt versus Gradual Withdrawal of Vitamin K Antagonist Treatment in Patients with Venous Thromboembolic Disease: Assessment of Hypercoagulability and Clinical Outcome Clinical Laboratory 46(11-12): 575-581
Kirchheimer, J.C.; Nong, Y.H.; Remold, H.G. 1988: IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes Journal of Immunology 141(12): 4229-4234
Ueno, T.; Kobayashi, N.; Maekawa, T. 1979: Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase Thrombosis and Haemostasis 42(3): 885-894
Collen, D.; De Cock, F.; Lijnen, H.R. 1984: Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys Thrombosis and Haemostasis 52(1): 24-26
Geratz, J.D.; Shaver, S.R.; Tidwell, R.R. 1981: Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation Thrombosis Research 24(1-2): 73-83
Zahavi, J. 1977: The role of platelets in myocardial infarction, ischemic heart disease, cerebrovascular disease, thromboembolic disorders and acute idiopathic pericarditis Thrombosis and Haemostasis 38(4): 1073-1084
Dayi, H.; Zhimin, X. 1997: Evaluation of the patency rate of infarct-related artery after intravenous urokinase in acute myocardial infarction by 90 minutes angiography. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(3): 184-186
Kornalik, F. 1977: Inhibition of experimental arterial and venous thrombosis by ecarin, a defibrinating enzyme Folia Haematologica 104(6): 833-838
Spartalis, M.A. 1994: Management of thromboembolic disease Journal of the National Medical Association 86(7): 487; 515
Poirier, R. 1971: Thromboembolic disease during pregnancy. 3 Phlebologie 24(2): 165-80 Contd
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
Gross, N.J. 1988: The use of anticholinergic agents in the treatment of airways disease Clinics in Chest Medicine 9(4): 591-598